Clinical Trial: Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid Tumors
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Advanced Solid Tumor
Study Type: INTERVENTIONAL
Official Title: Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid
Brief Summary:
The purpose of this research study is to evaluate the safety, tolerability and activity of VAX014 for intratumoral injections (VAX014) in patients with advanced solid tumors.VAX014 is a targeted oncolytic agent designed to kill tumor cells following intratumoral injection into advanced solid tumors.
Read more